Biotechnology News

September 17, 2014

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) announced today that Cephalon, Inc., a subsidiary of Teva Pharmaceutical Industries Ltd., has moved to dismiss with prejudice its first lawsuit alleging that Eagle’s...

September 17, 2014

SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that Matthew Walsh, Executive...

September 17, 2014

EMERYVILLE, Calif.--(BUSINESS WIRE)--Dr. Fanara will describe how KineMed’s biomarkers can be used to monitor disease progression and treatment response in neurodegenerative diseases such as Parkinson’s, ALS, Alzheimer’s & Huntington’s.

September 17, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enumeral has been awarded a Phase II SBIR contract from the National Cancer Institute to develop and deploy an advanced, automated system for human tissue immuno-oncology profiling.

September 17, 2014

ROCKLAND, Mass,--(BUSINESS WIRE)--EMD Serono, Inc.and Sutro Biopharma today announced a collaboration and license agreement to develop antibody drug conjugates (ADCs).

September 17, 2014

YAVNE, Israel--(BUSINESS WIRE)--Avraham Pharmaceuticals Raises $4.5 Million in Additional Investment Led by Yissum. The capital is intended for the on-going Phase 2b clinical trial of ladostigil.

September 17, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Tokai Pharmaceuticals Announces Pricing of Initial Public Offering

September 17, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Concert has initiated a Phase 1 clinical trial with CTP-730, a novel product candidate that is being developed under its strategic collaboration with Celgene.

September 17, 2014

WASHINGTON--(BUSINESS WIRE)--Members of the Association of Clinical Research Organizations (ACRO) have more than doubled in size in the past 10 years, employ more than 100,000 research professionals worldwide. New survey.

September 17, 2014

SAN DIEGO--(BUSINESS WIRE)--OncoSec Medical Expands Legal Team, Appoints Sheela Mohan-Peterson as General Counsel and Corporate Secretary

September 17, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ:AVEO) today announced that clinical data on ficlatuzumab, the Company’s hepatocyte growth factor (HGF) inhibitory antibody, as well as tivozanib, the Company’s inhibitor of vascular...

September 17, 2014

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced results from a Phase 2 study evaluating simtuzumab, an investigational inhibitor of lysyl oxidase-like-2 (LOXL2), in combination with gemcitabine for...

September 17, 2014

NEW YORK--(BUSINESS WIRE)--Trian Fund Management, L.P. (“Trian”), whose investment funds beneficially own approximately $1.6 billion of the outstanding shares of E. I. du Pont de Nemours and Company (NYSE: DD), today said it has sent a letter to...

September 17, 2014

OXFORD, England--(BUSINESS WIRE)--PharmaVentures Advises MedGenesis In Agreement For Its Potential Therapy For Parkinson's Disease.

September 17, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today announced that cobimetinib, an Exelixis-discovered compound, will be the subject of a clinical data presentation at the European Society for Medical Oncology (ESMO)...

September 16, 2014

VALENCIA, Calif.--(BUSINESS WIRE)--Advanced Bionics, a global leader in cochlear implant technology, announced today that the waterproof AquaCase™ container for the Naída CI processor has obtained FDA approval in the United States.

September 16, 2014

NEW YORK--(BUSINESS WIRE)--Retrophin, Inc. (NASDAQ:RTRX) today announced that Jeffrey Paley, MD has stepped down as a member of the Board of Directors to more fully devote time to his medical practice, and Marc Panoff has decided to leave his...

September 16, 2014

SEATTLE--(BUSINESS WIRE)--The Washington Biotechnology & Biomedical Association (WBBA) reports that more than 50 Washington life science transactions this year to date have surpassed $1 billion.

September 16, 2014

DANBURY, Conn.--(BUSINESS WIRE)--IMS Health (NYSE:IMS) announced today that Stefan Linn, senior vice president, Strategy & Global Product Management, will participate in a “fireside chat” at the Leerink Partners Services Roundtable in New...

September 16, 2014

NEW YORK--(BUSINESS WIRE)--Bristol Myers Squibb Announces Dividend

September 16, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) today launched an early access program for its new SNP genotyping platform, the JunoTM System, for its key production genomics customers and prospects.

September 16, 2014

PARIS--(BUSINESS WIRE)--Event report: Cellectis R&D/ Analyst Day; Genome Engineering & CART Cells: At the forefront of immuno-oncology

September 16, 2014

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE: AZN) today announced that the US Food and Drug Administration (FDA) approved MOVANTIK™ (naloxegol) Tablets C-II as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (...

September 16, 2014

--(BUSINESS WIRE)--Biotechnology Industry Organization:     WHAT: - BIO will present Governor Dennis Daugaard with the 2014 Food and Agriculture Governor of the Year Award - Governor Daugaard will deliver remarks   WHO: - South Dakota Governor...

September 16, 2014

HARTFORD, Conn.--(BUSINESS WIRE)--The Coalition Against Lyme and Related Borrelioses today called for DNA tests for faster, more reliable and effective testing for Lyme disease and related tick borne illnesses for better patient care.

September 16, 2014

MOUNT ARLINGTON, N.J.--(BUSINESS WIRE)--PDS, a leading global provider of intuitive data management software and solutions for life sciences research, announces that a top 5 pharma company has used TranSEND™ to successfully submit multiple SEND...

September 16, 2014

WOBURN, Mass.--(BUSINESS WIRE)--Aphios was awarded a NIH grant to develop a process for manufacturing cGMP cannabidiol (CBD) using its green drug manufacturing technology for clinical evaluation by NIH and other investigators.

September 16, 2014

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Vince & Associates Clinical Research, a premier provider of early phase clinical research services, announced the completion of enrollment of a human abuse liability (HAL) clinical trial of centranafadine...

September 16, 2014

WILLOW GROVE, Pa.--(BUSINESS WIRE)--NMS Labs Announces Crucial New Tool for Impaired Driving Investigation

September 16, 2014

BOSTON--(BUSINESS WIRE)--Halloran Consulting Group, Inc. (Halloran) today announced they have relocated from Waltham, MA to the Fort Point District of downtown Boston. With fortuitous timing, Halloran has simultaneously been recognized by Inc....

September 16, 2014

LOS ANGELES--(BUSINESS WIRE)--Targeted Medical Pharma, Inc. (OTCQB:TRGM), is scheduled to present the latest in therapeutic nutrition and medical food at SACHS Associated 14th Annual Biotech Europe Forum in Basel, Switzerland.

September 16, 2014

LONDON & AUDUBON, Pa.--(BUSINESS WIRE)--DrugDev and its President/CEO Ibraheem Mahmood are finalists for the SCRIP Awards. DrugDev provides technology-driven solutions to help investigators, sponsors and CROs do more clincal trials.

September 16, 2014

MONTREAL--(BUSINESS WIRE)--The interim analysis for THR-184 for acute kidney injury has been successfully completed. Thrasos announced that 200 patients have been enrolled to date in the clinical trial.

September 16, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN), a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today announced that Vikas Sharma, PhD, Director of...

September 16, 2014

FLORENCE, Italy--(BUSINESS WIRE)--CSL Behring announced today that the last patient has been treated as part of the REPLACE (Randomized Evaluation of fibrinogen versus PLACEbo in complex cardiovascular surgery) Phase III clinical trial. REPLACE...

September 16, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, Inc. (NASDAQ: GNCA), a clinical-stage biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that the peer-reviewed journal Virology has published...

September 16, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Quanterix today announced that Dr. Mark Roskey has joined Quanterix' leadership team as Vice President and General Manager, Applications and Reagents.

September 16, 2014

AUSTIN, Texas--(BUSINESS WIRE)--Ortho Kinematics‚ Inc. (OKI), a privately held healthcare diagnostic company focused on spine imaging informatics, announced today that it has entered into an agreement with Medtronic, giving Medtronic the ability...

September 16, 2014

TOREKOV, Sweden--(BUSINESS WIRE)--Nolato AB (STO:NOLAB) Nolato Medical Pharma Packaging now have the ability to print Braille, or other offset surface print, directly onto plastic containers. The process developed by Nolato Jaycare in the UK...

September 16, 2014

MORRISVILLE, N.C.--(BUSINESS WIRE)--Morrisville, NC, September 16, 2014 – Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) announces new company name and symbol effective September 19, 2014: Tenax Therapeutics Inc. (NASDAQ:TENX).